Caplin Point Laboratories' Injectables Facility in Puducherry Passes INVIMA Inspection in Colombia

Caplin Point Laboratories Ltd. has announced that the injectables facility of the company located at Puducherry has successfully passed an inspection conducted by INVIMA - Colombia. The inspection was carried out between December 8 and 12, 2025. The successful completion of the inspection is a significant step for the company, reinforcing its commitment to expanding its reach in Latin America and delivering high-quality, affordable medicines to the patient population in this region. This inspection also complements the company's already INVIMA approved Softgel section at the same site, aligning with its product strategy for expansion into the larger Latin American market for specialty injectable products.